Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Chem Biol Drug Des. 2013 Jul;82(1):106–118. doi: 10.1111/cbdd.12138

Figure 5.

Figure 5

T cells were collected from mice spleen and treated with FITC-labelled anti- CD48 along with peptide 6 at various concentrations to evaluate the competitive binding. A) unstained T-cells were observed in the lower left quadrant. B) Cells+ FITC-labelled anti-CD48; nearly 80% cells shifted into the lower right quadrant. C) Cells+ FITC-labelled anti-CD48+ peptide 6 100 µM. More than 50% cells were found to be unstained in the lower left quadrant. D) Cells+ FITC-labelled anti-CD48+ peptide 6 200 µM; more than 90% of cells in the lower left quadrant were found to be unstained.